Перегляд за автором "Tkalia, I.G."

Результати 1-3 з 3

Clinical significance of hormonal receptor status of malignant ovarian tumors

Tkalia, I.G.; Vorobyova, L.I.; Svintsitsky, V.S.; Nespryadko, S.V.; Goncharuk, I.V.; Lukyanova, N.Y.; Chekhun, V.F. (Experimental Oncology, 2014)

Objectives: To study hormonal receptor status (HRS) of malignant ovarian tumors (MOT) and determine its clinical significance. Patients and Methods: Retrospective analysis of case histories of 284 patients with MOT of ...
Increase of antitumor activity of cisplatin using agonist of gonadotropin-realising hormone and inhibitor of aromatase on the model of ascites ovarian tumor

Tkalia, I.G.; Vorobyova, L.I.; Grabovoy, A.N.; Svintsitsky, V.S.; Tarasova, T.О.; Lukyanova, N.Y.; Todor, I.N.; Chekhun, V.F. (Experimental Oncology, 2014)

Aim : To study antitumor activity of triptorelin — agonist of gonadotropin-releasing hormone and exemestane — inhibitor of aromatase in monotherapy and in combination with cisplatin on the model of receptor-positive for ...
The antitumor efficacy of cisplatin in combination with triptorelin and exemestane therapy for an ovarian cancer ascites model in Wistar rats

Tkalia, I.G.; Vorobyova, L.I.; Grabovoy, A.N.; Svintsitsky, V.S.; Tarasova, T.О. (Experimental Oncology, 2015)

Aim: To study antitumor activity of triptorelin — agonist of gonadotropin-releasing hormone and exemestane — inhibitor of aromatase in combination with cisplatin on the model of receptor-positive for estrogens and progesterone ...

Результати 1-3 з 3

Пошук